Hormone replacement therapy (HRT) involves administering hormones, often estrogen and progesterone, to treat symptoms of menopause and aging in women and andropause in men. Common symptoms associated with menopause and andropause include hot flashes, insomnia, night sweats, mood swings, decreased libido and bone density loss. HRT can effectively treat or reduce the severity of these symptoms. It often takes the form of pills, skin patches or gels. The global HRT market is driven by the rising prevalence of menopause among women worldwide owing to increased life expectancy. Around 1.1 billion women are expected to enter menopause by 2025. In addition, growing awareness about treatment options like HRT is also fueling market growth.
The Global Hormone Replacement Therapy Market is estimated to be valued at US$ 16,460.66 million in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period of 2024 to 2030.
Key Takeaways
Key players operating in the hormone replacement therapy market include PlayNetwork, Inc., TouchTunes Music Corporation, Sirius XM Holdings, Inc., Almotech Media Solutions, Imagesound, Easy on Hold, Soundnet Limited (Soundjack), Xenox Music & Media B.V., Qsic Pty Ltd., Express Melody, OpenEar Music, Auracle Sound, Cloud Cover Music, and Mood Media Corporation. These players are focusing on developing and launching innovative product formulations.
The major opportunities in the HRT market include an increasing emphasis on customized HRT regimens. Healthcare providers and patients are recognizing the need for individualized treatment approaches based on factors like symptoms, age, genetics and lifestyle. The market is also witnessing strong growth opportunities in Asia Pacific and Latin America driven by expanding medical infrastructure and rising disposable incomes in developing countries.
Key players are actively pursuing global expansion strategies in order to consolidate their market presence. Companies are exploring opportunities in high growth emerging markets through partnerships, acquisitions and establishing manufacturing facilities in such regions. For instance, leading players have expanded into countries in Asia Pacific, Latin America and Eastern Europe in the last five years.
Market Drivers
One of the major drivers for this market is the rising geriatric population worldwide. The number of people aged 65 and above is growing dramatically which is fueling the demand for HRT as age leads to hormonal changes. According to the UN, there were over 703 million people aged 65 years and above globally in 2019 which is projected to reach 1.5 billion by 2050.
Market Restraints
However, the market prospects are hindered to an extent by factors such as side effects associated with long term HRT usage. Hormone therapies have been linked to health complications including breast cancer, blood clots and strokes. Hence, associated safety concerns act as a major restraint for wider HRT adoption especially for preventive care. Stringent regulatory norms for new product approvals also pose a challenge for market players.
Segment Analysis
The Hormone Replacement Therapy Market Size is dominated by estrogen replacement therapy sub segment. This is because estrogen replacement therapy accounts for more than half of all hormone replacement therapy prescriptions as estrogen deficiency is more common among menopausal women. It is used to treat moderate to severe menopausal symptoms like hot flashes, night sweats, vaginal dryness etc. which are prevalent in almost 80% of menopausal women.
The estrogen replacement therapy sub segment is further divided into oral and transdermal estrogen. Among these, transdermal estrogen replacement therapy dominates due to its advantages over oral estrogen like bypassing the liver and causing fewer adverse reactions. Transdermal estrogens are delivered through the skin in the form of patches or gels.
Global Analysis
North America region accounts for the largest share in the global hormone replacement therapy market owing to established healthcare infrastructure, high awareness levels regarding menopause management and favorable reimbursement policies. The North America hormone replacement therapy market is estimated to reach US$ 68,970.5 Mn by 2030.
Asia Pacific region is expected witness the highest growth during the forecast period due to increasing patient pool suffering from menopause related health issues, growing healthcare spending, rising medical tourism and expansion of private healthcare sectors in emerging countries like India and China. Rising medical facilities, diagnostic centers and clinics in Asia pacific will further aid growth of hormone replacement therapy market in this region.
Explore more information on this topic, Please visit-
https://www.insightprobing.com/hormone-replacement-therapy-market-growth-and-trnds-analysis-share-size-demand-forecast/
Comments
0 comment